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† Discussion
background: There is uncertainty over whether maternal smoking is associated with birth defects. We conducted the ﬁrst ever
comprehensive systematic review to establish which speciﬁc malformations are associated with smoking.
methods: Observational studies published 1959–2010 were identiﬁed (Medline), and included if they reported the odds ratio (OR) for
having a non-chromosomal birth defect among women who smoked during pregnancy compared with non-smokers. ORs adjusted for poten-
tial confounders were extracted (e.g. maternal age and alcohol), otherwise unadjusted estimates were used. One hundred and seventy-two
articles were used in the meta-analyses: a total of 173 687 malformed cases and 11674 332 unaffected controls.
results: Signiﬁcant positive associations with maternal smoking were found for: cardiovascular/heart defects [OR 1.09, 95% conﬁ-
dence interval (CI) 1.02–1.17]; musculoskeletal defects (OR 1.16, 95% CI 1.05–1.27); limb reduction defects (OR 1.26, 95% CI
1.15–1.39); missing/extra digits (OR 1.18, 95% CI 0.99–1.41); clubfoot (OR 1.28, 95% CI 1.10–1.47); craniosynostosis (OR 1.33,
95% CI 1.03–1.73); facial defects (OR 1.19, 95% CI 1.06–1.35); eye defects (OR 1.25, 95% CI 1.11–1.40); orofacial clefts (OR
1.28, 95% CI 1.20–1.36); gastrointestinal defects (OR 1.27, 95% CI 1.18–1.36); gastroschisis (OR 1.50, 95% CI 1.28–1.76); anal
atresia (OR 1.20, 95% CI 1.06–1.36); hernia (OR 1.40, 95% CI 1.23–1.59); and undescended testes (OR 1.13, 95% CI 1.02–1.25).
There was a reduced risk for hypospadias (OR 0.90, 95% CI 0.85–0.95) and skin defects (OR 0.82, 0.75–0.89). For all defects combined
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conclusions: Birth defects that are positively associated with maternal smoking should now be included in public health educational
materials to encourage more women to quit before or during pregnancy.
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Introduction
Maternal smoking during pregnancy is an established risk factor for miscar-
riage/perinatal mortality, low birthweight, premature births and small
fetuses (DiFranza and Lew, 1995; Royal College of Physicians 2010; Shah
and Bracken, 2000; US Surgeon General, 2001, 2004). The biological
mechanisms of how tobacco smoke affect fetal development have been
examined in extensive human and laboratory studies, which show that
many of the 7000 chemicals can cross the placental barrier and have a
direct harmful effect on the unborn baby (BMA, 2004; Werler et al.,
1985; Quinton et al., 2008; Talbot, 2008; Rogers, 2009).
Despite the risks, many women still smoke during pregnancy; 17% in
England and Wales (ONS, 2006)a n d1 4 %i nt h eU S A( Tong et al.,
2009). The prevalence varies considerably with maternal age and edu-
cational/professionallevel. Inthe UK, the smoking prevalence during preg-
nancy was 45% among those aged ,2 0y e a r sc o m p a r e dw i t h9 %i nt h o s e
aged ≥35years;and29%inthoseinroutine/manualwork,comparedwith
7% classiﬁed as managerial/professional (ONS, 2006). In the USA, 20% of
pregnant women aged ,25 years smoked versus 9% among those aged
≥35 years (Tong et al., 2009); and it was 22% in those with ,12 years
of education versus 6.5% with .12 years (Williams et al., 2006).
In England and Wales, 3759 babies were born with a non-
chromosomal congenital anomaly in 2008; the ﬁve most common
defects were of the heart/cardiovascular system (27%), limbs (22%),
urinary (17%) and genital (11%) systems, and orofacial clefts (11%)
(ONS, 2010). In the USA there are .120 000 babies born with a
birth defect each year (March of Dimes, 2010): an annual incidence
of 3% (Parker et al., 2010).
Relatively few public health educational materials mention birth
defects as a possible outcome among pregnant women who smoke,
and those that do are hardly ever speciﬁc. This is probably because
of uncertainty over whether congenital defects are causally associated
with maternal smoking. Surprisingly, despite research studies spanning
50 years, there has never been a comprehensive systematic review of
smoking and congenital defects, except for orofacial clefts (Wyszynski
et al., 1997; Little et al., 2004). The purpose of our review is to estab-
lish which speciﬁc defects are associated with maternal smoking.
Methods
We conducted a systematic literature review of English articles published
1959 to February 2010 in Medline, using the PRISMA guidelines. The key-
words used were (abnormalit$ or defect$ or malformation$ or anomal$
or deﬁcienc$ or gastroschisis or omphalocele or atresia or cleft or cranio-
synostosis or clubfoot/talipes equinovarus or cryptorchidism or hypospa-
dias or spina biﬁda or anencephaly or strabismus or esotropia or exotropia
or polydactyly or syndactyly or adactyly or ﬁnger$ or toe$) AND (birth$
or pregnanc$ or infant$ or congenital or offspring) AND (maternal or
mother$ or women) AND (smok$ or cigarette$ or factor$ or indicator$
or exposure$). References were also checked with two US Surgeon Gen-
eral’s reports (US Surgeon General, 2004, 2010). We also examined
articles in Embase, and found no additional article to those already ident-
iﬁed using the above searches.
Any full paper when the abstract referred to maternal smoking or risk
factors was obtained. A total of 9328 abstracts were examined (S.B. and
A.H. independently), and 768 full papers were obtained, including those
identiﬁed from article references (see Supplementary data, Flow Chart
Figure). The inclusion criteria were: any observational study based on
women who smoked during pregnancy (the exposure); the article reported
the odds ratio (OR) or relative risk of having a defect among pregnant
smokers compared with non-smokers (the outcome), whether adjusted for
confounding or not, or it provided data that allowed the calculation of the
OR; and there must have been a control group (usually of unaffected births).
After excluding 91 articles that contained duplicate data, there were 177
eligible articles, of which 172 were included in the analyses, covering 101
different research studies. Five articles were not included in the analyses
because all controls had malformations other than the one of interest
(and so could possibly dilute an association with smoking). Instead, they
are summarized in the Supplementary data, table footnotes.
S.B. and A.H. extracted design characteristics and data from each paper.
The ORs were sometimes adjusted for potential confounders (e.g.
maternal age), either in the reported statistical analysis or by using
matched controls. Unadjusted estimates were used when adjusted ORs
were unavailable. Of the 101 studies, the affected cases were: live births
(n ¼ 74), only stillbirths (n ¼ 4) or mainly live births with some stillbirths
or elective abortions (n ¼ 23). In 12 studies the comparison group
included all other births unaffected by the defect of interest (i.e. those
without the defect plus those with other defects, though this is unlikely
to affect the ORs because the vast majority did not have an anomaly,
and would only slightly dilute an effect). In one study all controls had chro-
mosomal defects. For several disorders, such as musculoskeletal defects,
orofacial clefts and gastrointestinal disorders (e.g. gastroschisis and ompha-
locele), diagnoses were largely made at birth (or within the ﬁrst week).
However, for others, such as cardiovascular defects, craniosynostosis,
facial defects (e.g. of the eye), other gastrointestinal defects, and genitour-
inary defects, many studies ascertained affected cases up to 1 year after
birth or beyond, or when diagnoses were made in infancy (including refer-
rals for corrective treatment).
The study designs were cohort, case–control or surveys. Important
study characteristics for each defect are provided in the online supplemen-
tary data: such as geographical location, year of recruitment of study sub-
jects, time period following birth during which cases were ascertained (for
defects that might not be detected at birth), and matching or confounding
factors allowed for. Maternal smoking status and other characteristics
were obtained by questionnaires or interviews during early pregnancy
(prospectively), or shortly after birth using surveys, interviews or birth cer-
tiﬁcates (retrospectively). The 101 studies were therefore classiﬁed as pro-
spective cohort (n ¼ 16), prospective case–control (n ¼ 3), retrospective
case–control (n ¼ 62) or retrospective surveys (n ¼ 20). Several case–
control studies were matched for factors such as maternal age and birth
year, while others without matching reported that characteristics of
cases and controls were similar.
590 Hackshaw et al.Analyses were conducted using a random effects model, allowing for
heterogeneity (REVMAN, 2008), based on adjusted ORs from each
study (allowing for a range of potential confounders; see Supplementary
data), and if not available, the unadjusted estimate. In addition, analyses
were performed using only the adjusted estimates, and also where at
least allowance was made for maternal age and alcohol use (two main
potential confounders). Further subgroup analyses were restricted to
studies where smoking status was collected prospectively to avoid misre-
porting bias, in which smokers with an affected baby might be more likely
to report themselves as non-smokers. Heterogeneity between studies was
assessed by a test for heterogeneity and I
2 (Higgins et al., 2003). Publi-
cation bias was examined using funnel plots.
Results
The 172 reports together contain 173 687 cases with a congenital
defect and 11 674332 unaffected controls (see reference list for all
177 eligible articles). Figure 1 and Supplementary data, Table S1 sum-
marizes the pooled ORs from the meta-analysis for each body
system or speciﬁc defect, including ORs adjusted for potential con-
founders. Maternal smoking is associated with a signiﬁcant increased
risk for defects of the cardiovascular, musculoskeletal and gastroin-
testinal systems, the face including orofacial clefts, and cryptorchid-
ism. There appears to be a decreased risk for hypospadias and
Figure 1 Summary of the meta-analyses for maternal smoking in pregnancy and birth defects. The pooled ORs are shown for each body system and
speciﬁc defects (total number of malformed cases in brackets). CI: conﬁdence interval
*Umbilical, inguinal or ventral hernia. ‘Oesophageal ﬁstula’ is ‘oesophageal atresia/tracheoesophageal ﬁstula’.
Maternal smoking in pregnancy and birth defects 591Figure 2 Forest plots for (a) cardiovascular/heart defects (Kelsey 1978 had no standard error, OR ¼ 1.08), (b) all musculoskeletal defects (two
studies had no standard error: Kelsey 1978 OR ¼ 0.93, and Hemminki 1981 OR ¼ 1.35), (c) limb reduction defects, (d) digit anomaly (ie polydactyly,
syndactyly and adactyly), (e) clubfoot (Kelsey 1978 had no standard error, OR ¼ 1.22; and the pooled OR excluding Shiono 1986 Kaiser is 1.35, 95%
CI 1.17–1.54), and (f) craniosynostosis. Studies are ranked according to size of the odds ratio.
592 Hackshaw et al.skin defects among smokers. There is probably no association with
defects of the genitourinary, respiratory or central nervous systems
(CNS).
Cardiovascular/heart defects
There is a modest (9%) but signiﬁcant increased risk, OR 1.09 [95%
conﬁdence interval (CI) 1.02–1.17, P ¼ 0.009] from 25 studies
(29 288 malformed cases, 2.09 million controls); Supplementary
data, Table S2a and Fig. 2a. Seven studies each had signiﬁcant
excess risks. The pooled OR from 19 studies of heart defects only
is also 1.09 (Supplementary data, Table S2b and Fig. S1); 5 were stat-
istically signiﬁcant. When we restricted the analyses to only those
studies that had at least 1-year follow-up to ascertain affected cases,
the pooled OR was similar: 1.10 (95% CI 1.02–1.18).
It was not clear whether any speciﬁc heart anomaly (e.g. ventricular
septal defects) had a greater association with maternal smoking. The
study with the largest number of affected cases (n ¼ 3067; Malik
et al., 2008) suggested that the strongest effect could be on ventricular
septal defects (OR 1.34, 95% CI 1.08–1.65), and atrial septal defects
(OR 1.98, 95% CI 1.53–2.57). The ORs for other types were: 1.26
(right ventricular outﬂow tract obstruction), 0.96 (left ventricular
outﬂow tract obstruction) and 1.00 (conotruncal defects).
Musculoskeletal defects and craniosynostosis
Musculoskeletal defects include a range of problems associated with
the muscles, bones and limbs. There is a signiﬁcant 16% increase in
risk associated with maternal smoking (OR 1.16, 95% CI 1.05–1.27,
P ¼ 0.002) from 25 studies (41 159 malformed cases, 1.2 million con-
trols); Supplementary data, Table S3 and Fig. 2b. There was evidence
of heterogeneity, but this was not present in some subgroup analyses.
Six studies reported evidence of a dose–response relationship
(Alderman et al., 1991; Czeizel et al., 1994; Honein et al., 2001;
Skelly et al., 2002; Man and Chang, 2006; Parker et al., 2009).
Eight studies of limb reduction defects (2915 malformed cases,
2.4 million controls)—the absence or severe underdevelopment of
the hands or feet (transverse limb reductions), or of the radius,
tibia, ulna or ﬁbula (longitudinal limb reductions)—all reported
increased risks; Supplementary data, Table S4 and Fig. 2c. Two
studies each had signiﬁcant results (Czeizel et al. 1994; Kallen,
2000), one with a dose–response relationship (Czeizel et al., 1994).
The excess risk is 26% (OR 1.26, 95% CI 1.15–1.39, P , 0.00001),
and no heterogeneity (P ¼ 0.44, I
2 ¼ 0%).
Among six studies of digit anomalies (missing, fused or extra ﬁngers
or toes; 14150 malformed cases, 7.6 million controls), two were each
signiﬁcant, and the pooled OR is 1.18 (95% CI 0.99–1.41); Sup-
plementary data, Table S5 and Fig. 2d.
Figure 2 Continued.
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controls) seven were statistically signiﬁcant, but one with a decreased
risk. Four reported evidence of a dose–response relationship (Alder-
man et al., 1991; Honein et al., 2001; Skelly et al., 2002; Parker et al.,
2009). The pooled excess risk is 28% (OR 1.28, 95% CI 1.10–1.47,
P ¼ 0.0009); Supplementary data, Table S6 and Fig. 2e. However,
examination of the ﬁve statistically signiﬁcant positive studies suggests
that the effect could be greater (≥40%).
Four studies of diaphragmatic hernia did not show an association
with maternal smoking; Supplementary data, Table S7 and Fig. S2.
The pooled OR is 0.94 (P ¼ 0.63).
Craniosynostosis is where sutures of the skull have fused prema-
turely, deforming the shape of the head. Of the ﬁve studies (1131 mal-
formed cases, 1.4 million controls), three were each signiﬁcant, with
evidence of a dose–response relationship (Alderman et al., 1994;
Kallen, 1999; Honein and Rasmussen, 2000); Supplementary data,
Table S8 and Fig. 2f. The pooled OR is 1.33 (95% CI 1.03–1.73,
P ¼ 0.03), with no heterogeneity (P ¼ 0.09).
Facial defects (face, eyes or ears)
Twelve studies together show a 19% increased risk of a facial defect
(OR 1.19, 95% CI 1.06–1.35, P ¼ 0.004), excluding orofacial clefts,
and seven were each signiﬁcant; Supplementary data, Table S9 and
Fig. 3a (5876 malformed cases, 2.6 million controls). Two reported
evidence of a dose–response relationship (Chew et al., 1994; Tornq-
vist et al., 2002). When results for eye defects only were examined
(e.g. anophthalmia, microphthalmia, esotropia, exotropia and optic
nerve hypoplasia), the excess risk is 25% (OR 1.25, 95% CI 1.11–
1.40, P ¼ 0.0001); Supplementary data, Table S10 and Fig. 3b. Five
of the nine studies on eye defects (4541 malformed cases,
2.3 million controls) were each signiﬁcant, and one reported evidence
of a dose–response relationship (Chew et al., 1994).
Thirty-eight studies have examined the risk of cleft lip or palate
(23 441 malformed cases, 8.1 million controls), and 13 were each sig-
niﬁcant. The pooled OR is 1.28 (95% CI 1.20–1.36, P , 0.00001);
Supplementary data, Table S11 and Fig. 3c. Six reported evidence of
a dose–response relationship (Khoury et al., 1987; Shaw et al.,
1996a; Chung et al., 2000; Honein et al., 2001; Little et al., 2004;
Shi et al., 2007). The effects of cleft lip and palate were not separated
because a previous systematic review (25 cohort and case–control
studies) indicated that the risks are not too dissimilar: pooled ORs
were 1.34 (95% CI 1.25–1.44) for cleft lip, with or without cleft
palate, and 1.22 (95% CI 1.10–1.35) for cleft palate alone (Little
et al.; 2004).
Defects of the gastrointestinal system
Gastrointestinal defects include abdominal wall defects and a range of
abnormalities of the pharynx, oesophagus, intestine, colon, bile ducts,
gallbladder and liver. Although there are 35 studies in the
meta-analysis (11580 malformed cases, 9.7 million controls), the
degree of heterogeneity was not great (P ¼ 0.02, I
2 ¼ 36%); Sup-
plementary data, Table S12 and Fig. 4a. One reported evidence of a
dose–response relationship (Chung and Myrianthopoulos, 1975).
The excess risk is 27% (OR 1.27, 95% CI 1.18–1.36, P , 0.00001);
or OR ¼ 1.22 (95% CI 1.14–1.31) excluding gastroschisis/
omphalocele.
Five speciﬁc types of defect could be reliably examined. There is a
clear association with gastroschisis, OR 1.50 (95% CI 1.28–1.76), and
Figure 3 Forest plots for (a) facial defects, (b) eye defects only, and (c) cleft lip or palate. Studies are ranked according to size of the odds ratio.
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controls); Supplementary data, Table S13, Fig. 4b). All but one
showed an increased risk, and ﬁve studies were each signiﬁcant. The
effect on omphalocele is less and not statistically signiﬁcant, OR
1.19 (95% CI 0.95–1.48), and P ¼ 0.14 from seven studies; Sup-
plementary data, Table S14 and Fig. S3.
There is an association with anal atresia (OR 1.20, 95% CI 1.06–
1.36, and P ¼ 0.005, from seven studies (1679 malformed cases,
7.8 million controls); Supplementary data, Table S15, Fig. 4c, and
umbilical/inguinal/ventral hernias, OR 1.40 (95% CI 1.23–1.59, and
P , 0.00001) from four studies, 941 malformed cases and 374 086
controls; Supplementary data, Table S16, Fig. 4d. All four studies of
hernias showed an increased risk. There is no evidence for
oesophageal atresia/tracheoesophageal ﬁstula, OR 0.93 (95% CI
0.81–1.07 and P ¼ 0.32) from seven studies, Supplementary data,
Table S17 and Fig. S4.
Defects of the genitourinary system
These defects included those of the genital organs, urinary bladder,
kidney, ureter and urethra. When considered together, there does
not seem to be a clear association with maternal smoking, OR 1.05
(95% CI 0.98–1.12, and P ¼ 0.20), from 40 studies, with 24081 mal-
formed controls and 8.2 million controls; Supplementary data, Table
S18, Fig. 4e. An analysis of non-speciﬁc genitourinary defects produced
an OR of 1.02 95% CI 0.91–1.14); which became 0.93 (95% CI 0.84–
1.04) when based only on studies that had at least 1-year follow-up
during which cases were ascertained. The OR for the genital system
alone is 1.01, 95% CI 0.93–1.10, P ¼ 0.76 (based on 32 studies; Sup-
plementary data, Table S19 and Fig. S5).
The OR for cryptorchidism (undescended testes), based on 18
studies (8753 malformed cases, 98627 controls) is 1.13 (95% CI
1.02–1.25, P ¼ 0.02); Supplementary data, Table S20, Fig. 4f.
There is a reduction in risk for hypospadias (abnormal urethra),
based on 15 studies (12 047 malformed cases and 1.5 million con-
trols); OR 0.90 (95% CI 0.85–0.95, P ¼ 0.0004), with little hetero-
geneity, P ¼ 0.28 and I
2 ¼ 16%. Two of the 15 studies on
hypospadias were signiﬁcant (Supplementary data, Table S21 and
Fig. S6).
The pooled OR is 1.15, 95% CI 0.95–1.39, for renal/urinary tract
defects, which is not statistically signiﬁcant (P ¼ 0.15 from 9 studies,
3330 malformed cases and 7.7 million controls; Supplementary data,
Table S22 and Fig. S7).
Defects of the CNS
When all CNS defects were considered together, there seems to be a
modest excess risk; OR 1.10 (95% CI 1.01–1.19, P ¼ 0.02);
Supplementary data, Table S23 and Fig. S8a. Seven of the 29 studies
(14 739 malformed cases, 8.2 million controls) were each signiﬁcant,
Figure 3 Continued.
Maternal smoking in pregnancy and birth defects 595Figure 4 Forest plots for (a) all gastrointestinal defects (Kelsey 1978 had no standard error, OR ¼ 1.55), (b) gastroschisis, (c) anal atresia, (d)
umbilical/ventral/inguinal hernias, (e) all genitourinary defects, and (f) cryptorchidism. Studies are ranked according to size of the odds ratio.
596 Hackshaw et al.one with a decreased risk. However, among 17 studies of spina biﬁda
and anencephaly (the most common CNS defects) there is no evi-
dence of an association (5910 malformed cases, 7.9 million controls);
OR 0.97, 95% CI 0.86–1.10, and P ¼ 0.66; Supplementary data, Table
S24 and Fig. S8b. While it is possible that there may be an effect of
maternal smoking on some CNS defects, the evidence is not sufﬁ-
ciently clear.
Defects of the respiratory system and skin
There were six studies of defects of the respiratory system, i.e. nasal
passage, larynx and lungs (633 malformed cases, 415653 controls).
The OR is 1.11, 95% CI 0.95–1.30, but not signiﬁcant, P ¼ 0.18; Sup-
plementary data, Table S25 and Fig. S9. There is a clear reduction in
risk for defects of the skin (e.g. pigmentation disorders and moles)
among ﬁve studies (3789 malformed cases, 386 576 controls). All
Figure 4 Continued.
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OR is 0.82, 95% CI 0.75–0.89 (P , 0.00001), with little heterogeneity
(I
2 ¼ 0%); Supplementary data, Table S26 and Fig. S10.
All congenital abnormalities considered
together
There are 38 studies in which the OR for all birth defects combined
was reported (67716 malformed cases, 2.2 million controls). Only
ﬁve were each signiﬁcant, one of which had a decreased risk. The
pooled OR of 1.01 (95% CI 0.96–1.07) suggests no effect; Sup-
plementary data, Table S27 and Fig. S11. Initially, this seems inconsist-
ent with the sections above. However, while smoking is positively
associated with several disorders (and sometimes only modestly), it
also appears to be protective for hypospadias and skin defects, and
there is probably no effect on diaphragmatic hernia, genital defects
(except cryptorchidism), and defects of the CNS, renal/urinary tract
and respiratory systems. Furthermore, maternal smoking is not associ-
ated with chromosomal disorders such as Down syndrome (Rudnicka
et al., 2002), but studies often include these when reporting on all
abnormalities. Therefore, by examining all defects together a diluted
effect is expected. By applying the pooled ORs estimated for each
body system to the distribution of types of birth defects (ONS,
2010) and assuming a maternal smoking prevalence of 17% (ONS,
2006), an OR of about 1.10 is expected. This assumes that an affected
case has only one defect, but there is evidence that women who
smoke are more likely to have a baby with ≥2 defects: excess risks
15% (Kallen, 2000), 19% (Yushkiv et al., 2005) and 61% (Bitsko
et al., 2007), compared with non-smokers. Therefore, to allow for
‘double counting’, the OR for all defects together is probably
between 1.05 and 1.10. Most studies would be underpowered to
detect this effect size. Furthermore, under-reporting bias in retrospec-
tive studies might be more likely to inﬂuence an OR as low as 1.05–
1.10. The pooled OR among the three largest prospective studies,
each with .2000 cases (Kallen 2000; Queisser-Luft et al., 2002;
Morales-Suarez et al., 2006) was 1.04 (95% CI 1.01–1.07), consistent
with expectation.
Study quality, heterogeneity and
publication bias
The pooled ORs where smoking status was obtained prospectively
were similar to those given above, e.g. cardiovascular disease (OR
1.14 versus 1.09 based on all studies), limb reduction defects (OR
1.28 versus 1.26), gastrointestinal defects (OR 1.38 versus 1.27), gas-
troschisis (OR 1.65 versus 1.50) and oral clefts (OR 1.24 versus 1.28).
The main concern is adjustment for confounding, another indicator of
study quality. Supplementary data, Table S1 compares the pooled ORs
from the main analysis with those only based on studies that allowed
for potential confounders (by including them as matching variables in
case–control studies, or in the statistical analysis). The ORs were
similar, and those that were statistically signiﬁcant remained so, indi-
cating that the effect of confounding was minimal. Pooled ORs only
from studies that allowed for at least maternal age and alcohol use
(perhaps the two most important potential confounders) were also
examined. The point estimates were again generally similar to those
given in the sections above, e.g. cardiovascular disease (OR 1.20
versus 1.09), limb reduction defects (OR 1.30 versus 1.26), oral
clefts (OR 1.40 versus 1.28), gastrointestinal defects (OR 1.30
versus 1.27), gastroschisis (OR 1.50 versus 1.50), cryptorchidism
(OR 1.12 versus 1.13), hypospadias (OR 0.87 versus 0.90) and skin
defects (OR 0.82 versus 0.82). Sometimes, adjusted estimates were
not reported, but the authors stated that the results were similar to
the unadjusted ones. Recreational drug use was not often measured,
and so could not be reliably addressed.
There is some evidence that folic acid or other multivitamins could
reduce the birth prevalence of defects other than of the neural tube
(Czeizel, 2005), though the evidence is not consistent (Bower et al.,
2006). Multivitamins would be a potential confounder if non-smoking
women were more likely to use them than smokers and multivitamins
were protective for many defects, because this could create a spurious
association between smoking and birth defects. Few studies included
in our meta-analyses adjusted for peri-conceptual multivitamin use
(including folic acid), but those that did still reported an increased
risk for maternal smoking (e.g. Malik et al., 2008 for cardiovascular
disease, Wasserman et al., 1996 for limb reduction defects, and Van
Rooij et al., 2001 and Shi et al., 2007 for orofacial clefts). Similarly, if
there was a signiﬁcant confounding effect of multivitamin use,
looking only at studies that recruited subjects after say 1992 should
produce a clear excess risk for all defects. However, when we did
this, the pooled OR was only 1.06 (compared with 1.01 for all
studies).
There was evidence of signiﬁcant heterogeneity for some defects/
body systems but not all. For cardiovascular defects and orofacial
clefts, the test for heterogeneity became non-signiﬁcant (P ¼ 0.48
and P ¼ 0.10, respectively) when the subgroup analysis was based
on prospective studies only, even though the pooled estimates were
not materially different from all studies. There was heterogeneity for
all gastrointestinal defects considered together, but not when analysed
according to speciﬁc sub-type (i.e. gastroschisis, omphalocele, anal
atresia and hernias). We could not ﬁnd factors that explained the het-
erogeneity for all musculoskeletal defects, but what is of note is that 18
out of 25 studies showed an increased risk, of which eight were each
statistically signiﬁcant. When examining subgroups of musculoskeletal
defects the number of studies in the meta-analyses was insufﬁcient
to evaluate heterogeneity reliably (for example, digit anomalies, club-
foot, facial defects and eye defects).
Publication bias would occur if studies that found little or no associ-
ation between maternal smoking and birth defects were less likely to
be published, so a meta-analysis would be skewed by studies that did
ﬁnd an association. We examined funnel plots for all of the
meta-analyses, and none indicated signiﬁcant asymmetry, which is a
sign of publication bias. We therefore concluded that this bias was
not present to a material extent. Furthermore, the observation that
most studies reported results that were not statistically signiﬁcant
(often interpreted to be a ‘negative’ study), provides further evidence
that studies were likely to be published, regardless of what they found.
Discussion
This ﬁrst ever comprehensive systematic review of congenital birth
defects shows which are associated with maternal smoking during
pregnancy. There are modest effects on digit anomalies, cryptorchid-
ism and defects of the heart and musculoskeletal system (ORs 1.09–
1.19); and larger effects (ORs 1.25–1.50) on limb reduction defects,
598 Hackshaw et al.clubfoot, oral clefts and defects of the eyes and gastrointestinal system
(especially gastroschisis and abdominal hernias). These defects should
now be referred to by clinicians or other health professionals when
providing advice to women planning a pregnancy, or early on in
pregnancy.
Maternal smoking appears to have a protective effect for hypospa-
dias and skin defects (ORs 0.82–0.90); not unexpected given that
active smoking reduces the risk for some adult disorders (Wald and
Hackshaw, 1996).
There is unlikely to be an effect (positive or negative) on defects of
the CNS, respiratory and genitourinary (except cryptorchidism and
hypospadias) systems.
It is uncertain what proportion of the study populations had ultra-
sound screening for malformations during pregnancy. This can inﬂu-
ence the results when studies are based on live births only because,
if widely used, ultrasound can lead to termination of pregnancy for
some defects and thus reduce the prevalence at birth. However, it
might increase the detection of some internal abnormalities, e.g.
cardiac and renal, which could be missed at birth.
The studies were conducted or published between 1959 and 2010
with different designs, so they are expected to be of variable quality.
The intention of this review was to be inclusive, and objective assess-
ment of quality was made by subgroup analyses based on features that
could be associated with bias or confounding. Women, especially
those with an affected baby, could misreport their smoking status
when based on self-reports (compared with blood cotinine measure-
ments; Shipton et al., 2009), but this bias would tend to under-
estimate the ORs. When the meta-analyses only included studies in
which smoking status was obtained prospectively, similar pooled
ORs were found. Potential confounding does not seem to be an
issue; similar point estimates were found when only adjusted ORs
were pooled, including allowance for both maternal age and alcohol
(some individual studies made the same conclusion). Only English
language articles were included in the review. However, examination
of non-English language articles for a sample of the publication years
did not produce additional studies. Furthermore, we examined 768
full papers and included 177 articles, so any missed studies are likely
to have a negligible effect. Follow-up is an important consideration
for defects that may not be readily observed at birth, because if too
short, then defects could be missed and an association becomes
diluted or not detected. Many studies had at least 1-year follow-up,
and analysis restricted to such studies (e.g. for cardiovascular or geni-
tourinary defects) produced almost identical pooled ORs.
Much of the literature on the harmful effects of smoking in preg-
nancy concentrates on other complications, such as fetal death, fetal
growth restriction and prematurity. The mechanisms (Werler et al.,
1985; Talbot, 2008; Rogers, 2009) are not precisely understood but
are thought to include: the vasoconstrictor action of nicotine causing
reduced blood ﬂow to the placenta; carbon monoxide binding to hae-
moglobin so that less oxygen is available for placental and fetal tissues,
leading to fetal hypoxia; disruption of vascular neogenesis; and disturb-
ance of endothelial function in the maternal (Quinton et al., 2008)a s
well as, presumably, in the fetal circulations. How some or all of these
mechanisms can cause a variety of congenital malformations is
unknown. Abnormal morphogenesis can certainly be produced by
toxins and/or hypoxia/ischemia interfering with cell proliferation or
migration or both. The timing of such an insult relative to sensitive
or critical periods of organogenesis, which may present only small
windows of opportunity (a few days or even hours), combined with
different thresholds for damage in fetal tissues, could determine
which organ or system is affected. Interaction between constituents
of tobacco smoke and other chemicals, particularly recreational
drugs, are likely to be quite common. Some of these (e.g. cocaine
and dexamphetamine) also have vasoconstrictor actions and may be
important in the aetiology of gastroschisis (Morrison et al., 2005)
but these data were not collected in most studies so it was not poss-
ible to examine the potential confounding effect reliably.
There are several reasons why the associations found are likely to
be causal (consistent with the Bradford–Hill criteria for causality).
There is biological plausibility, including laboratory experiments, and
established harm in children and adults for a wide range of disorders.
In many studies (i.e. the prospective ones) we can establish that the
exposure (smoking) occurred before the pregnancy outcome. The
ORs were statistically signiﬁcant, and there was an effect after allowing
for potential confounders. Although many individual studies did not
have sufﬁcient statistical power to reliably examine (and therefore
report) dose–response relationships, several found evidence that
the risk of the defect of interest increased with increasing cigarette
consumption, for the abnormalities for which signiﬁcant pooled ORs
were found. There is a general consistency in the ORs estimated
from studies conducted in different geographical regions (where the
birth defect prevalence could vary), even though women have differ-
ent lifestyle habits and medical care, either of which could affect the
birth defect prevalence.
Most of the malformations associated with maternal smoking have
physical and psychological morbidity for the infant and parents,
often lifelong and with signiﬁcant healthcare service costs for hospital-
izations and length of stay (Russo and Elizhauser, 2004; Robbins et al.,
2007; Wehby and Cassell, 2010). The estimated total hospital charges
for treating the defects for which there are positive associations was
 $2.1 billion in the USA in 2003 (Robbins et al., 2007). Of this,
around $46 million could be crudely attributed to maternal smoking,
after applying population attributable risk proportions (using our esti-
mated ORs and the US smoking prevalence during pregnancy) to the
2003 US costs. Congenital heart defects are a common and serious
birth anomaly, and infants often require several operations during
their lifetime. Similarly, limb reduction defects, hand and foot
anomalies, including clubfoot, and oral clefts are all visible, and
despite surgical treatment (sometimes painful), may result in disability.
Disorders of the gastrointestinal system also require corrective
treatments.
It is worthwhile considering the use of nicotine replacement therapy
(NRT) during pregnancy. It is available in several different forms
(patches, gum, and spray) and has been shown to be effective in
giving up smoking. There is some evidence that it is safe in pregnancy,
with respect to stillbirth and fetal growth restriction, and it is being
used increasingly, with the support of national guidelines (for
example, in the UK). However, there is little information on congenital
malformations and a cautious attitude is advisable. The view that NRT
is safer than smoking is widely held but of special concern are those
women who take NRT and continue to smoke as well, especially in
the ﬁrst trimester.
Further studies could examine in more detail the ﬁnancial and other
healthcare and societal costs for the defects identiﬁed here. While the
Maternal smoking in pregnancy and birth defects 599risk of miscarriage and low birthweight has had some effect on
smoking habits, many women still smoke just before and during preg-
nancy. Other research could be conducted to ascertain whether the
risk of lifelong physical abnormalities to the child might encourage
more women to quit, especially younger ones. In England and
Wales (ONS 2008) the prevalence of a birth defect was 139.8
per 10000 among women aged ,20 years, higher than those aged
30–34 years (116.5 per 10000). Some of this difference will be
related to the much higher smoking prevalence in the younger age
group (45%), acknowledging less use of peri-conceptual folic acid
(because there are more unplanned pregnancies), and a much lower
risk of a chromosomal defect.
In conclusion, maternal smoking in pregnancy is an important risk
factor for several major birth defects. These speciﬁc defects should
be included in public health educational information to encourage
more women to quit smoking before or early on in pregnancy, and
to particularly target younger women and those from lower socio-
economic groups, in which smoking prevalence is greatest.
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